B+
Bull case
25%
Probability
Target price
$14.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
LFST
Lifestance Health GroupBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The August 6 8-K showed accelerating scale economics: revenue grew 26%, Center Margin grew 41%, Adjusted EBITDA grew 94%, and management raised FY 2026 guidance versus the ranges disclosed with Q1 results. Continued clinician additions, visit growth, productivity, and operating leverage could support re-rating.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +4.0.
What can break
High valuation leaves limited tolerance for slower clinician growth, visit volumes, revenue per visit, or margin expansion.
Momentum
90
Value
54
Sentiment
61
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $12.70 · Bull $14.50 · Bear $8.80Analysis 2026-08-08; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $14.20
Why
Momentum90 · Δ7d +2.8
Value54 · Δ7d -0.0
Sentiment61 · Δ7d +4.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +4.0.
Contradictions & invalidation
- • High valuation leaves limited tolerance for slower clinician growth, visit volumes, revenue per visit, or margin expansion.
- • Net long-term debt exceeded cash at the end of Q2, constraining financial flexibility.
- • The setup remains execution-sensitive: growth depends on clinician recruitment, productivity, visit volumes, and revenue per visit.
Catalyst clock
2026-11-06
Confirmed Q2 results and raised FY 2026 outlook
Lead driver: Sentiment · See AI snapshot
Momentum
90
9% active weight
Current posture
7d trendImproving
Δ7d
+2.8
Δ21d
-0.9
Value
54
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+1.8
Sentiment
61
62% active weight
Current posture
7d trendImproving
Δ7d
+4.0
Δ21d
-2.4
Why this grade
Composite grade B. Momentum 90.4 / Value 53.7 / Sentiment 61.1
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-08. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$12.70
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$8.80
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$4.79B
Beta
1.11
Shares Out
382.06M
P/E (TTM) · Derived
502.0
P/S (TTM)
2.01
P/FCF (TTM)
22.97
Rev YoY
+26.1%
EPS YoY
-722.4%
Gross Margin
+30.1%
Op Margin
+5.1%
Net Debt
$225.88M
Current Ratio
1.38
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data